The Influence of Gastrointestinal Biomolecules on Solid-State Transformations in Pharmaceutical Particulates
Molecular Pharmaceutics · 2023
DOI: 10.1021/acs.molpharmaceut.3c00442 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2023. Verfasst von Anas Aljabbari und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen 2100, Denmark. Hauptthemen laut MEDLINE: Indomethacin, Phospholipids. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Novo Nordisk Fonden.
Abstract (Originalsprache)
Adsorption of gut relevant biomolecules onto particles after oral administration of solid oral dosage forms is expected to form a "gastrointestinal corona", which could influence solution-mediated solid-state transformations on exposure of drug particles to gastrointestinal fluids. Low-frequency Raman (LFR) spectroscopy was used in this study to investigate in situ solid-state phase transformations under biorelevant temperature and pH conditions along with the presence of biomolecules. Melt-quenched amorphous indomethacin was used as a model solid particulate, and its solid-state behavior was evaluated at 37 °C and pH 1.2-6.8 with or without the presence of typical bile salt/phospholipid mixtures emulating fed-state conditions. Overall, a change in the solid-state transformation pathway from amorphous to crystalline drug was observed, where an intermediate ε-form that initially formed at pH 6.8 was suppressed by the addition of endogenous gastrointestinal biomolecules. These solid-state changes were corroborated using time-resolved synchrotron small- and wide-angle X-ray scattering (SAXS/WAXS). Additionally, the bile salt and phospholipid mixture partly prevented the otherwise strong aggregation between drug particles at more acidic conditions (pH ≤ 4.5) and helped to shift the balance against the intrinsic hydrophobicity of indomethacin as well as the plasticization effect brought about by the physiological temperature (i.e., the stickiness arising from the supercooled liquid state at 37 °C). The overall results highlight the importance of evaluating the impact that endogenous biomolecules may have on the solid-state characteristics of drug molecules in dissolution media, where analytical tools such as LFR spectroscopy can serve as an attractive avenue for accessing time-resolved solid-state information on time-scales that are difficult to achieve with other techniques such as X-ray diffraction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen 2100, Denmark.
- Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Parkville 3052, Victoria, Australia.
ORCID-Profile: Anas Aljabbari, Thomas Rades, Ben J Boyd
Förderung
- Novo Nordisk Fonden
Zitieren
APA
Aljabbari, A., Kihara, S., Rades, T., Boyd, B. J., & Be Rziņš, K. R. (2023). The Influence of Gastrointestinal Biomolecules on Solid-State Transformations in Pharmaceutical Particulates. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.3c00442
Vancouver
Aljabbari A, Kihara S, Rades T, Boyd BJ, Be Rziņš KR. The Influence of Gastrointestinal Biomolecules on Solid-State Transformations in Pharmaceutical Particulates. Molecular Pharmaceutics. 2023. doi:10.1021/acs.molpharmaceut.3c00442
BibTeX
@article{Aljabbari2023,
author = {Aljabbari, Anas and Kihara, Shinji and Rades, Thomas and Boyd, Ben J and Be Rziņš, Ka Rlis},
title = {The Influence of Gastrointestinal Biomolecules on Solid-State Transformations in Pharmaceutical Particulates},
journal = {Molecular Pharmaceutics},
year = {2023},
doi = {10.1021/acs.molpharmaceut.3c00442}
}
EUVIMED